Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH) announced the publication of vocal biomarker data from its RECOVER Phase 3 clinical trial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE